Connection
Shelley Crary to Hemangioendothelioma
This is a "connection" page, showing publications Shelley Crary has written about Hemangioendothelioma.
|
|
Connection Strength |
|
 |
|
 |
|
1.300 |
|
|
|
-
Mack JM, Crary SE. How we approach coagulopathy with vascular anomalies. Pediatr Blood Cancer. 2022 08; 69 Suppl 3:e29353.
Score: 0.828
-
Crary SE. Hemostasis and thrombosis risks and management in vascular anomalies. Hematology Am Soc Hematol Educ Program. 2024 12 06; 2024(1):718-723.
Score: 0.244
-
Borst AJ, Eng W, Griffin M, Ricci KW, Engel E, Adams DM, Dayneka J, Cohen-Cutler SJ, Andreoli SM, Wu MD, Wheeler AP, Heym KM, Crary SE, Nakano TA, Schulte RR, Setty BA, McLean TW, Pahl KS, Intzes S, Pateva I, Teitelbaum M, Zong Z, Li Y, Jeng MR. Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study. Pediatr Blood Cancer. 2024 Mar; 71(3):e30779.
Score: 0.228
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|